Researchers compared a novel reverse transcription loop-mediated isothermal amplification method to the gold standard, reverse transcription polymerase chain reaction, and assessed the accuracy in detecting SARS-CoV-2.
In hospitalized patients with COVID-19, the routine use of molecular point-of-care testing in emergency department admissions was associated with a large reduction in time to results compared with laboratory PCR testing.
Study authors assessed the specificity and positive predictive value of a customized, institutional, early warning score for predicting decompensation in COVID-19 patients.
Study authors investigated UCP-LF circulating anodic antigen (CAA) as a potential diagnostic test for Schistosoma haematobium in pregnant women.
Point-of-care testing is associated with large reductions in the time to results for patients presenting with suspected COVID-19.
A comparative assessment of 5 immunoassays for SARS-CoV-2 showed that these assays achieved sensitivity and specificity of at least 98%.
In settings where acid-fast bacilli pulmonary diseases are suspected, gastric aspirate culture may be helpful for diagnosing Mycobacterium avium complex and M kansasii pulmonary disease.
The reissued EUA allows for fingerstick blood samples to be tested in point-of-care settings.
Researchers compared 3 immunochromatographic assays (Sienna™, Wondfo®, and Prometheus™) to detect antibodies against SARS-CoV-2 in serum samples, using RT-qPCR as a reference.
Research results highlighted the need for continued supplemental NAATs for oropharyngeal samples being tested for Nisseria gonorrhoeae.
